• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Gastroenterology

Incomplete polyp resection increases risk of future and advanced neoplasia

byHarsh Shah
October 8, 2021
in Gastroenterology, Oncology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Incomplete resection of colon segments was shown to significantly increase the risk of future neoplasia compared to segments with complete resection.

2. Advanced neoplasia was shown to be more likely in incomplete segment resections compared to complete resections.

Evidence Rating Level: 2 (Good)

Study Rundown: An estimated account of incomplete polyp resection occurs for 10% to 30% of all post-colonoscopy colorectal cancer (CRC). However, only indirect evidence is available between incomplete polyp resection and CRC after colonoscopy. As such, this study compared the rate of neoplasia in segments with prior incomplete resection compared to the rate of neoplasia in segments with prior complete resection. Incomplete resection was defined as the presence of neoplastic tissue in any marginal biopsies. The study determined incomplete polyp resection significantly increased the risk of future neoplasia and advanced neoplasia compared to colon segments with complete resection. The observational cohort study was limited by potential patient bias due to incomplete patient follow-up. Nonetheless, this study’s results are significant, and its findings highlight the importance of polypectomy technique to ensure complete resection thereby reducing the risk of future neoplasia.

Click to read the study in Annals of Internal Medicine

Relevant Reading: Rates of incomplete resection of 1- to 20-mm colorectal polyps: a systematic review and meta-analysis

In-Depth [prospective cohort]: This observational cohort study enrolled 233 participants across two academic medical centers in the United States. Participants included in the study had resection of a 5- to 20-mm neoplastic polyp, documentation of complete or incomplete resection, and had a surveillance exam. Participants without appropriate documentation or a surveillance exam were excluded from this study. Incomplete resection was defined as the presence of neoplastic tissue in any marginal biopsies. Participants with documented incomplete resection were recommended for a surveillance exam within one year, while participants with a documented complete resection were provided surveillance recommendations based on current guidelines. The primary outcome was the proportion of segments with neoplasia at first surveillance colonoscopy. Of the 233 participants, 166 (71%) participants had at least one surveillance exam by the end of the study. Overall, the median time to surveillance was shorter in the incomplete resection group (median, 17 months; interquartile range, 12 to 47 months) compared to the complete resection group (median, 45 months; interquartile range, 35 to 62 months). In regard to the primary outcome, the risk for neoplasia was significantly greater in the incomplete (52%) group compared to the complete (23%) group (risk difference [RD], 28%; 95% confidence interval [CI], 9% to 47&; P = 0.004). Additionally, participants in the incomplete (18%) group were more likely to have advanced neoplasia compared to the complete (3%) group (RD, 15%; 95% CI, 1% to 29%; P = 0.034). Finally, an incomplete polyp resection was the strongest independent factor associated with neoplasia (odds ratio, 3.0; 95% CI, 1.12 to 8.17). Taken together, incomplete polyp resection was associated with an increased risk of future neoplasia and advanced neoplasia compared to complete resection.

RELATED REPORTS

Pembrolizumab did not show overall survival benefit in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer

Addition of atezolizumab to capecitabine + bevacizumab is not clinically beneficial in the treatment of refractory metastatic colorectal cancer

Higher abundance of dietary sulfur-reducing microbes was associated with increased risk of colorectal cancer

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: colorectal cancercomplete resectionincomplete resectionneoplasiapolypectomy
Previous Post

High Amplitude Low Frequency–Music Impulse Stimulation may decrease depressive symptoms in adults with mild-to-moderate depression

Next Post

Statin therapy initiation is associated with diabetes progression

RelatedReports

Oophorectomy associated with reduced cancer risk and all-cause mortality for BRCA1/2 patients
Oncology

Pembrolizumab did not show overall survival benefit in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer

April 18, 2022
Noninvasive imaging method detects and evaluates size of metastases
Chronic Disease

Addition of atezolizumab to capecitabine + bevacizumab is not clinically beneficial in the treatment of refractory metastatic colorectal cancer

February 25, 2022
Normal renal ultrasound only rules out high grade vesicoureteral reflux in infants
Gastroenterology

Higher abundance of dietary sulfur-reducing microbes was associated with increased risk of colorectal cancer

January 4, 2022
Provision of medically-tailored meals linked with lower admissions and medical spending
Wellness

Wellness Check: Nutrition

December 30, 2021
Next Post
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial

Statin therapy initiation is associated with diabetes progression

#VisualAbstract ESCORT-HU highlights the real-life positive benefit-to-risk ratio of hydroxyurea in patients with sickle cell disease

#VisualAbstract ESCORT-HU highlights the real-life positive benefit-to-risk ratio of hydroxyurea in patients with sickle cell disease

How This Painter’s Artful Pants Caught the Eye of Bella Hadid

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]
  • Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers
  • APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.